These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31632272)

  • 1. Naoxintong Capsule Inhibits the Development of Cardiovascular Pathological Changes in Bama Minipig Through Improving Gut Microbiota.
    Zhang WJ; Su WW; Li PB; Rao HY; Lin QW; Zeng X; Chen TB; Yan ZH; Liu H; Yao HL
    Front Pharmacol; 2019; 10():1128. PubMed ID: 31632272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naoxintong Capsule Alternates Gut Microbiota and Prevents Hyperlipidemia in High-Fat-Diet Fed Rats.
    Lu Y; Wan H; Wu Y; Yang J; Yu L; He Y; Wan H; Li C
    Front Pharmacol; 2022; 13():843409. PubMed ID: 35387330
    [No Abstract]   [Full Text] [Related]  

  • 3. Naoxintong capsule remodels gut microbiota and ameliorates early-stage atherosclerosis in apolipoprotein E-deficient mice.
    Wan H; Lu Y; Yang J; Wan H; Yu L; Fang N; He Y; Li C
    Phytomedicine; 2024 Jul; 129():155662. PubMed ID: 38728917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated metabolomics and gut microbiome to the effects and mechanisms of naoxintong capsule on type 2 diabetes in rats.
    Yan Z; Wu H; Zhou H; Chen S; He Y; Zhang W; Chen T; Yao H; Su W
    Sci Rep; 2020 Jul; 10(1):10829. PubMed ID: 32616735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potential of NaoXinTong Capsule on the developed diabetic nephropathy in db/db mice.
    Yang S; Chen Y; Duan Y; Ma C; Liu L; Li Q; Yang J; Li X; Zhao B; Wang Y; Qian K; Liu M; Zhu Y; Yang X; Han J
    Biomed Pharmacother; 2019 Oct; 118():109389. PubMed ID: 31545275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of Danhong Injection combined with Naoxintong Capsule on cerebral ischemia-reperfusion injury in rats.
    Wan J; Wan H; Yang R; Wan H; Yang J; He Y; Zhou H
    J Ethnopharmacol; 2018 Jan; 211():348-357. PubMed ID: 28986333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cardioprotective properties and the involved mechanisms of NaoXinTong Capsule.
    Han J; Tan H; Duan Y; Chen Y; Zhu Y; Zhao B; Wang Y; Yang X
    Pharmacol Res; 2019 Mar; 141():409-417. PubMed ID: 30660824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NaoXinTong Capsules inhibit the development of diabetic nephropathy in db/db mice.
    Yang S; Liu M; Chen Y; Ma C; Liu L; Zhao B; Wang Y; Li X; Zhu Y; Gao X; Kong D; Duan Y; Han J; Yang X
    Sci Rep; 2018 Jun; 8(1):9158. PubMed ID: 29904053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NaoXinTong Inhibits the Advanced Atherosclerosis and Enhances the Plaque Stability in Apolipoprotein E Deficient Mice.
    Yang X; Sun L; Li Y; Ma C; Yang J; Zhang W; Zhao B; Jia L; Duan Y; Han J; Li X; Chen Y
    J Cardiovasc Pharmacol; 2016 Mar; 67(3):203-11. PubMed ID: 26485209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NaoXinTong Inhibits the Development of Diabetic Retinopathy in db/db Mice.
    Liu M; Pan Q; Chen Y; Yang X; Zhao B; Jia L; Zhu Y; Han J; Li X; Duan Y
    Evid Based Complement Alternat Med; 2015; 2015():242517. PubMed ID: 25821481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Energy Metabolism Study on the Efficacy of Naoxintong Capsules against Myocardial Infarction in a Rat Model.
    Zhao J; Ouyang Y; Wang H; Lai H; Hu S; Tang L; Yang H; Wu H
    Oxid Med Cell Longev; 2022; 2022():3712500. PubMed ID: 35915610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NaoXinTong Enhances Atorvastatin-induced Plaque Stability While Ameliorating Atorvastatin-induced Hepatic Inflammation.
    Yang X; Li Y; Sun L; Liu Y; Ma C; Chen Y; Tan H; Li Q; Li X; Wang Y; Duan Y; Zhao B; Han J
    J Cardiovasc Pharmacol; 2017 Jan; 69(1):55-64. PubMed ID: 27828790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NaoXinTong Capsule Inhibits Carrageenan-Induced Thrombosis in Mice.
    Li Q; Chen Y; Zhao D; Wei Z; Zhang S; Chen Y; Wang Y; Qian K; Zhao B; Zhu Y; Gao X; Dong P; Li X; Duan Y; Han J; Yang X
    J Cardiovasc Pharmacol; 2018 Jul; 72(1):49-59. PubMed ID: 29738376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naoxintong restores collateral blood flow in a murine model of hindlimb ischemia through PPARδ-dependent mechanism.
    Chen L; Zhang L; Fang Z; Li C; Yang Y; You X; Song M; Coffie J; Zhang L; Gao X; Wang H
    J Ethnopharmacol; 2018 Dec; 227():121-130. PubMed ID: 30170078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naoxintong capsule for treating cardiovascular and cerebrovascular diseases: from bench to bedside.
    Zhang WJ; Chen RQ; Tang X; Li PB; Wang J; Wu HK; Xu N; Zou MF; Luo SR; Ouyang ZQ; Chen ZK; Liao XX; Wu H
    Front Pharmacol; 2024; 15():1402763. PubMed ID: 38994201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of Naoxintong capsule alone and in combination with ticagrelor and atorvastatin in rats with Qi deficiency and blood stasis syndrome.
    Zhang WJ; Su WW; Lin QW; He Y; Yan ZH; Wang YG; Li PB; Wu H; Liu H; Yao HL
    Pharm Biol; 2020 Dec; 58(1):1006-1022. PubMed ID: 32985308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial protective effect and transcriptome profiling of Naoxintong on cardiomyopathy in zebrafish.
    Hu M; Liu P; Lu S; Wang Z; Lyu Z; Liu H; Sun Y; Liu F; Tian J
    Chin Med; 2021 Nov; 16(1):119. PubMed ID: 34775978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Red pitaya betacyanins protects from diet-induced obesity, liver steatosis and insulin resistance in association with modulation of gut microbiota in mice.
    Song H; Chu Q; Yan F; Yang Y; Han W; Zheng X
    J Gastroenterol Hepatol; 2016 Aug; 31(8):1462-9. PubMed ID: 26699443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naoxintong attenuates Ischaemia/reperfusion Injury through inhibiting NLRP3 inflammasome activation.
    Wang Y; Yan X; Mi S; Li Z; Wang Y; Zhu H; Sun X; Zhao B; Zhao C; Zou Y; Hu K; Ding X; Sun A; Ge J
    J Cell Mol Med; 2017 Jan; 21(1):4-12. PubMed ID: 27785882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of "Multiple Components-Multiple Targets-Multiple Pathways" Associated with Naoxintong Capsule in the Treatment of Heart Diseases Using UPLC/Q-TOF-MS and Network Pharmacology.
    Ma X; Lv B; Li P; Jiang X; Zhou Q; Wang X; Gao X
    Evid Based Complement Alternat Med; 2016; 2016():9468087. PubMed ID: 27123036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.